scholarly journals Dinosaurs, Racial Anxiety, and Curatorial Intervention: Whiteness and Performative Historiography in the Museum

2021 ◽  
Vol 70 (4) ◽  
pp. 101-120
Author(s):  
Scott Magelssen

This essay argues that the staged encounters between museum visitors and dioramic display of dinosaur fossils in natural history and science museum spaces have been designed to capitalize on and performatively reify white anxiety about the exotic other using the same practices reserved for representing other historic threats to white safety and purity, such as primitive “savages” indigenous to the American West, sub-Saharan Africa, the Amazon, and other untamed wildernesses through survival-of-the-fittest tropes persisting over the last century. Dinosaur others in popular culture have served as surrogates for white fears and anxieties about the racial other. The author examines early dioramic displays of dinosaurs at New York’s American Museum of Natural History and conjectural paintings by artists like Charles R. Knight to argue that the historiographic manipulation of time, space, and matter, enabled and legitimized by a centering of the white subject as protagonist, has defined how we understand dinosaurs and has structured our relationship with them as (pre)historical objects. Exposing the ways in which racist tropes like white precarity have informed historiographical practices in dinosaur exhibits offers a tool for interrogating how racist ideologies have permeated the formations of modernity that inform our modes of inquiry.

Author(s):  
Lawrence Omo-Aghoja ◽  
Emuesiri Goodies Moke ◽  
Kenneth Kelechi Anachuna ◽  
Adrian Itivere Omogbiya ◽  
Emuesiri Kohworho Umukoro ◽  
...  

Abstract Background Coronavirus disease (COVID-19) is a severe acute respiratory infection which has afflicted virtually almost all nations of the earth. It is highly transmissible and represents one of the most serious pandemics in recent times, with the capacity to overwhelm any healthcare system and cause morbidity and fatality. Main content The diagnosis of this disease is daunting and challenging as it is dependent on emerging clinical symptomatology that continues to increase and change very rapidly. The definitive test is the very expensive and scarce polymerase chain reaction (PCR) viral identification technique. The management has remained largely supportive and empirical, as there are no officially approved therapeutic agents, vaccines or antiviral medications for the management of the disease. Severe cases often require intensive care facilities and personnel. Yet there is paucity of facilities including the personnel required for diagnosis and treatment of COVID-19 in sub-Saharan Africa (SSA). It is against this backdrop that a review of key published reports on the pandemic in SSA and globally is made, as understanding the natural history of a disease and the documented responses to diagnosis and management is usually a key public health strategy for designing and improving as appropriate, relevant interventions. Lead findings were that responses by most nations of SSA were adhoc, paucity of public health awareness strategies and absence of legislations that would help enforce preventive measures, as well as limited facilities (including personal protective equipment) and institutional capacities to deliver needed interventions. Conclusion COVID-19 is real and has overwhelmed global health care system especially low-income countries of the sub-Sahara such as Nigeria. Suggestions for improvement of healthcare policies and programs to contain the current pandemic and to respond more optimally in case of future pandemics are made herein.


PLoS ONE ◽  
2012 ◽  
Vol 7 (3) ◽  
pp. e32369 ◽  
Author(s):  
Nikos Pantazis ◽  
Charles Morrison ◽  
Pauli N. Amornkul ◽  
Charlotte Lewden ◽  
Robert A. Salata ◽  
...  

2007 ◽  
Vol 44 (4) ◽  
pp. 491
Author(s):  
Charles B Holmes ◽  
Robin Wood ◽  
Gary Maartens ◽  
Kenneth A Freedberg ◽  
Elena Losina

Author(s):  
Paul H. Skelton ◽  
Ernst R. Swartz ◽  
Emmanuel J. Vreven

The identity of Barbus capensis, as described by Andrew Smith (1841), is reviewed following a careful examination of the lectotype in the Natural History Museum, London. Evidence shows clearly that it represents a specimen of the Berg-Breede River whitefish or ‘witvis’ and not the species known as the Clanwilliam yellowfish, to which it was attributed until recently. The original illustration of the species is shown to be a composite of these two different species. A replacement name for the Clanwilliam yellowfish is drawn from the earliest described synonym, Labeobarbus seeberi (Gilchrist & Thompson, 1913). Following widespread recognition that the genus Barbus Daudin, 1805 does not occur in sub-Saharan Africa, the generic status of the Berg-Breede River whitefish (witvis) and other tetraploid cyprinines of southern Africa is reviewed, taking genetic and morphological characters into account. Five distinct lineages, each representing a genus, are recognized, including the genera Pseudobarbus Smith, 1841 and Cheilobarbus Smith, 1841, and three new genera described herein: Amatolacypris gen. nov., Sedercypris gen. nov. and Namaquacypris gen. nov.


2017 ◽  
Vol 1 (6) ◽  
pp. 533-537
Author(s):  
Lorenz von Seidlein ◽  
Borimas Hanboonkunupakarn ◽  
Podjanee Jittmala ◽  
Sasithon Pukrittayakamee

RTS,S/AS01 is the most advanced vaccine to prevent malaria. It is safe and moderately effective. A large pivotal phase III trial in over 15 000 young children in sub-Saharan Africa completed in 2014 showed that the vaccine could protect around one-third of children (aged 5–17 months) and one-fourth of infants (aged 6–12 weeks) from uncomplicated falciparum malaria. The European Medicines Agency approved licensing and programmatic roll-out of the RTSS vaccine in malaria endemic countries in sub-Saharan Africa. WHO is planning further studies in a large Malaria Vaccine Implementation Programme, in more than 400 000 young African children. With the changing malaria epidemiology in Africa resulting in older children at risk, alternative modes of employment are under evaluation, for example the use of RTS,S/AS01 in older children as part of seasonal malaria prophylaxis. Another strategy is combining mass drug administrations with mass vaccine campaigns for all age groups in regional malaria elimination campaigns. A phase II trial is ongoing to evaluate the safety and immunogenicity of the RTSS in combination with antimalarial drugs in Thailand. Such novel approaches aim to extract the maximum benefit from the well-documented, short-lasting protective efficacy of RTS,S/AS01.


1993 ◽  
Vol 47 (3) ◽  
pp. 555-556
Author(s):  
Lado Ruzicka

Crisis ◽  
2011 ◽  
Vol 32 (1) ◽  
pp. 43-51 ◽  
Author(s):  
Eugene Kinyanda ◽  
Ruth Kizza ◽  
Jonathan Levin ◽  
Sheila Ndyanabangi ◽  
Catherine Abbo

Background: Suicidal behavior in adolescence is a public health concern and has serious consequences for adolescents and their families. There is, however, a paucity of data on this subject from sub-Saharan Africa, hence the need for this study. Aims: A cross-sectional multistage survey to investigate adolescent suicidality among other things was undertaken in rural northeastern Uganda. Methods: A structured protocol administered by trained psychiatric nurses collected information on sociodemographics, mental disorders (DSM-IV criteria), and psychological and psychosocial risk factors for children aged 3–19 years (N = 1492). For the purposes of this paper, an analysis of a subsample of adolescents (aged 10–19 years; n = 897) was undertaken. Results: Lifetime suicidality in this study was 6.1% (95% CI, 4.6%–7.9%). Conclusions: Factors significantly associated with suicidality included mental disorder, the ecological factor district of residence, factors suggestive of low socioeconomic status, and disadvantaged childhood experiences.


Sign in / Sign up

Export Citation Format

Share Document